Candida urinary tract infections in elderly patients are becoming increasingly common. The risk factors for the development of candiduria include old age, use of broad-spectrum antibiotics, corticosteroids and indwelling urethral catheters, as well as diabetes mellitus, urological abnormalities, and hematological malignancies. The presence of signs and symptoms of infection are unusual, and the intensity of fungal growth in culture does not correlate with the outcome. Elderly patients often present with atypical signs and symptoms of infection. Careful assessment of the patient's clinical status should be undertaken before treatment is initiated. The indications for antifungal therapy are the same for older and younger individuals, and the initial antifungal therapy should be selected based on the infecting organism and local epidemiology. Fluconazole is the mainstay of treatment. On the other hand, Candida glabrata is more common in elderly patients and is often refractory to fluconazole therapy. The selection of drug therapy for elderly patients should consider the comorbidities, risk of drug-drug interactions, and dose adjustment for physiological function.
EPIDEMIOLOGY AND MICROBIOLOGICAL ASPECTS
Candiduria is a rare phenomenon in the general population and occurs in ＜1% of clean-voided urine samples, but it affects 5-10% of positive urine cultures in hospitals and tertiary care facilities, particularly patients in the intensive care unit (ICU) with indwelling urethral catheters [1, 3] . Candida species were reported to be the third most common organism isolated from urine, after Escherichia coli and Enterococcus species, in 1-day point prevalence surveys of urine cultures obtained from hospitalized patients in Europe [12] .
Candida albicans is the most commonly isolated pathogen from urine, accounting for 50-70% of isolated pathogens [3, 4, 7] . Candida glabrata and Candida tropicalis are the next most common species, and each accounts for 10-35% of cases [13, 14] . C. glabrata is increasingly reported as a cause of candidemia and develops in certain types of patients, such as those with hematological malignancies and transplant recipients. In the largest prospective study of renal transplant recipients, approximately 50% of all isolated organisms were C. glabrata and 30% were C. albicans [15] .
In addition, C. glabrata is detected more commonly in elderly patients with candidemia and candiduria and is very uncommon in neonates and young children [16] [17] [18] [19] [20] [21] [22] . In elderly patients, the intrinsic resistance of Candida species to fluconazole and the need for treatment with amphotericin B is a concern that has an increased the risk of nephrotoxicity [23] . Candida parapsilosis (1-7%), Candida krusei (1-2%), and other unusual Candida species are detected less commonly in urine [23] .
FEATURES OF ELDERLY PATIENTS
A range of physiologic and morphological changes occur during the aging process, resulting in older patients being potentially more vulnerable to infections, particularly from fungal species.
The aging process is characterized by a decreased immunological response to infection because of the functional insufficiency of monocytes and macrophages, which leads to inadequate phagocytosis [24] . Lymphocyte changes are also noted in the elderly population. Mature T-cells lose their memory capacity, resulting in poor and/or altered cytokine production [25] . Furthermore, there is a decrease in the number of circulating B-cells, and their response to antigenic challenges through immunoglobulin production is weaker [26] .
The renal and hepatic function is also impaired during the aging process. The glomerular filtration rate (GFR) decreases by 1% per year. On the other hand, this is not confirmed by serum creatinine to a certain level, because a 25% rise in the serum creatinine level actually represents a substantial decrease in GFR, probably up to 50% [27] . The hepatic function is decreased during aging because of the decrease in the total liver volume, hepatic blood flow, and protein synthesis. These factors can affect various phase I drug metabolism reactions, such as hydroxylation, dealkylation, and reduction, which are performed by microsomal cytochrome p450 [28, 29] . These renal and hepatic function impairments are associated with serious clinical problems with drugs dependent on renal and hepatic excretion.
Polypharmacy in the elderly is another important issue with regard to both the adverse effects and drug interactions.
In a recent study, approximately 75% of the elderly population were treated with at least four drugs, which are more medications than in the younger population. Furthermore, elderly patients also receive drugs in a more inappropriate manner [30] [31] [32] . The drugs most commonly used in the elderly 
Hematogenous Route
Hematogenous seeding is the most common route of renal infections, such as renal candidiasis during an episode of candidemia. Although this event is usually asymptomatic with regard to urinary symptoms, many experimental animal studies have reported the development of multiple microabscesses throughout the cortex after intravenous administration of C. albicans [34] . After the fungi penetrate through the glomeruli into the proximal tubules, the fungi are shed into the urine [35] . Autopsy studies have revealed the presence of renal cortical microabscesses in most patients who die with invasive candidiasis [36] .
Ascending Route
Retrograde ascending infections are the most common routes for genitourinary tract infections. This infection is observed more often in females than males because females have a shorter urethra and frequently have a vulvovaginal colonization of organisms. Although the pathogenesis of ascending infection by Candida has not been studied extensively, spread from the perineum into the bladder leads to colonization and then retrograde spread leads to an infection of the upper urinary tract, particularly concomitant with vesicoureteral reflux or an obstruction of urinary flow [34, 37] . Urethral catheterization can lead to infection by the introduction of organisms into the bladder during the procedure or by the migration of organisms along the surface of the catheter from the external periurethral surfaces.
Chronic indwelling urethral catheters can aggravate the situation thorough biofilm formation and the persistence of the organism, which leads to obstruction and difficulty in eradicating the organism [37] .
CLINICAL MANIFESTATIONS
Candiduria is asymptomatic in most patients, even in patients with hematogenous spread to the renal cortex [3] .
If candidemia develops, however, the signs of a systemic infection, such as fever, chills, and hypotension, can be found.
Patients with Candida UTI from the ascending route show similar symptoms to patients with bacterial infections.
Patients with Candida pyelonephritis usually exhibit fever, chills, and flank pain, similar to the symptoms of bacterial pyelonephritis [38] .
If Candida UTI occurs in the bladder, the patients report If a fungus ball, which is a mass of hyphae and yeast cells, is formed in the collecting system, the patients may complain of increasing flank pain and may become oliguric.
If the fungal ball leads to a ureteral obstruction, acute colicky flank pain and fever may develop [40] . A fungus ball that forms in the bladder can remain asymptomatic until it obstructs the ureters and/or urethra.
Elderly patients often present with atypical signs and symptoms of infection, and a delayed diagnosis is possible if combined with altered mentality [41] .
DIAGNOSIS
When candidal organisms are present in the urine, the major concern is whether this finding represents a significant infection of the urinary tract, colonization of the bladder, or contamination of the urine sample [42] . Unfortunately, there is no optimal sensitive diagnostic method available to distinguish these different possibilities, and a clinical assessment must be relied on in many circumstances. In patients with persistent candiduria, the major concern is whether there is bladder colonization, cystitis, or upper 
TREATMENT
The risk of developing candidemia from candiduria is low.
In a large prospective surveillance study, only seven (1.3%) out of 530 patients with candiduria developed candidemia after a 10 week follow-up [3] . A similar study reported that only five out of 233 patients with candiduria in the ICU developed candidemia due to the same species 2 to 15 days later [43] . In a clinical and molecular analysis to examine the relationship between candidemia and concomitant candiduria, only four (2.8%) of cases with candidemia showed the genotypic same species of Candida strains between two specimens [44] . For these reasons, the significance and the treated and untreated patients [45] .
Asymptomatic Candiduria
In patients with candiduria, who undergo a urological procedure, the risk of candidemia following urinary tract instrumentation is high. Therefore, treatment with fluconazole should be given before and immediately after the procedure [46, 47] . Neutropenic patients with candiduria should be treated because neutropenia can minimize any related symptoms, indicating a high likelihood that candiduria reflects the upper tract infection and candidemia [48] . In very low birth weight neonates, candiduria is often a marker of invasive candidiasis and infections of the upper urinary tract. Therefore, although related symptoms are not observed, candiduria should always be treated in this popu-
In patients with an indwelling urethral catheter and asymptomatic candiduria, treatments with antifungal agents are ineffective in eradicating candiduria and the long-term clinical outcomes will not improve [49] .
Symptomatic Candiduria
Symptomatic candiduria can present with cystitis, pyelonephritis, prostatitis, and epididymo-orchitis. Each specific Candida UTI must be treated with the appropriate antifungal agents.
In symptomatic Candida cystitis, fluconazole is the drug of choice for most species of Candida, particularly C. albicans.
The recommended dose is 200 to 400 mg daily, administered orally, for two weeks. On the other hand, C. glabrata, C. krusei, and other less common resistant species sometimes do not show susceptibility to fluconazole. Flucytosine can be considered for refractory Candida cystitis. Flucytosine is also concentrated in urine and most isolated C. glabrata are susceptible [50] . Generally, flucytosine therapy is recommended at a dose of 25 mg/kg every 6 to 8 hours for 7 to 10 days only because resistance can rapidly develop when this agent is used for extended periods. In addition, the potential toxicity from a high rate of cellular turnover, such as in the bone marrow and gastrointestinal mucosa, is a major concern [23,51]. Intravenous amphotericin B injections can be considered in refractory infections or in patients with unusually severe symptoms. The dosage and duration have not been established, but a 0.3 to 1 mg/kg intravenous injection for one or more doses, generally 1 to 7 days, is recommended [23, 51] . Bladder irrigation with amphotericin B is another approach for the treatment of Candida cystitis. The most common dose is 50 mg amphotericin B diluted in 1 L of sterile water to give a concentration of 50 µg/ml [52] . On the other hand, the relapse rate after bladder irrigation is high and this strategy is rarely needed except for persistent cystitis by fluconazole-resistant organisms [53] .
Renal parenchymal infection is generally the result of an antegrade infection and is treated the same as candidemia.
Retrograde infections of the kidneys can also develop due to the retrograde spread of the organism in patients with obstructive uropathy, DM, and concomitant bacteriuria.
Fluconazole is the agent of choice for pyelonephritis [48] .
Generally, a daily oral dose of 400 mg for two weeks is Lipid formulations of amphotericin B should not be used for treating renal candidiasis because the failure of this form has been reported [54] .
The treatment approaches to Candida prostatitis have not been determined because Candida prostatitis is uncommon and the current approaches are based on individual case reports not from randomized controlled trials. Fluconazole has been used on susceptible organisms and is recommended at 400 mg per day for four weeks because the drug does not accumulate in the prostate. On the other hand, the achieved concentrations might not be sufficient to eradicate some strains [51] . Amphotericin B is a commonly used antifungal agent for Candida prostatitis. In many reports, surgical drainage for an abscess and resection of prostate tissue are important for therapy [55, 56] . [59] . An invasive procedure is almost always required to relieve the obstruction and remove the mass. If access to the renal pelvis through nephrostomy tubes is available, local irrigation with amphotericin B or fluconazole can be considered [60, 61] .
Treatment of Complications
Intermittent saline irrigation, percutaneous endoscopic disruption and drainage, and percutaneous irrigation with streptokinase can also be performed to facilitate the breakdown and passage of fungus balls [62, 63] .
Antifungal Agent
The selection of an appropriate antifungal agent must consider the antifungal susceptibility of the organism and the ability of the antifungal agent to achieve the adequate concentrations in the urine.
Oral fluconazole, which is excreted into the urine as an active drug and achieves high urine levels, is the agent of choice for the treatment of Candida UTI [48] . Most Candida The recommended dose is 0.3 to 1.0 mg/kg per day for 5 to 7 days, but even a single-dose with 0.2 to 1.0 mg/kg has been shown to be effective [64] . The lipid formulations of amphotericin B, which show reduced nephrotoxicity, do not show adequate concentrations in the urine, and failure of these formulations has been reported [54] .
Flucytosine is also valuable in treating fluconazoleresistant C. glabrata-induced UTI. Flucytosine achieves high concentrations in the urine and is active against many isolated C. glabrata. On the other hand, C. krusei is not susceptible to flucytosine. The recommended dose is 25 mg/kg every six hours daily for 7 to 10 days and 14 days for cystitis and upper UTI, respectively [48, 51] . Nevertheless,
